Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

FDA Highlights: Abatacept shows efficacy for Glomerulosclerosis

Written by | 8 Jan 2014

by Bruce Sylvester – Abatacept, an FDA-approved treatment of rheumatoid arthritis could become the first targeted therapy for focal segmental glomerulosclerosis glomerulosclerosis (FSGS), a condition that usually causes… read more.

ESOT 2013: Outcomes with tacrolimus-based immunosuppression after kidney transplantation with standard or extended-criteria donor organs: the OSAKA study

Written by | 24 Oct 2013

Bernhard Banas, Regensburg, Germany – Prolonged-release tacrolimus administered once-daily provides high rates of graft survival and reduction in biopsy-confirmed acute rejection (BCAR), with a manageable tolerability profile, in patients… read more.

ESOT 2013 Report – Retransplantation of abdominal organs

Written by | 23 Oct 2013

Re-transplantation is the only option available for salvaging a failed abdominal graft. As the outcomes after primary transplantations continue to improve, even with the increasing use of extended-criteria… read more.

ESOT 2013 Report – Managing infectious complications in transplant recipients

Written by | 22 Oct 2013

Invasive microbial infections are a major cause of morbidity and mortality in organ transplantation patients. The satellite symposia sponsored by Astellas Pharma at ESOT 2013 discussed the challenge… read more.

ESOT 2013 Report – Pushing the limit in clinical science

Written by | 21 Oct 2013

by Peter Friend, Oxford, UK – The 16th ESOT Congress in Vienna 2013 was one of ESOT’s most comprehensive arrangements to date, with more than 3,500 attendees and… read more.

ESOT 2013 Report – Academic, industrial and regulatory barriers to progress in transplant immunosuppression

Written by | 21 Oct 2013

Randall Morris, San Francisco, USA – Failure to make therapeutic progress is a real challenge in the transplantation field. On the face of it, the goals set up… read more.

ESOT 2013 Report – Joint Session ESOT & IPTA: Tackling the transition

Written by | 18 Oct 2013

Richard Trompeter, London, UK; Jo Wray, London, UK; Lorraine Bell, Montreal, Canada – The transition from paediatric to adult transplantation services is a major challenge for adolescent transplant… read more.

ESOT 2013 Report – Joint Session ESOT & IPTA: Tackling the transition

Written by | 18 Oct 2013

Richard Trompeter, London, UK; Jo Wray, London, UK; Lorraine Bell, Montreal, Canada – The transition from paediatric to adult transplantation services is a major challenge for adolescent transplant… read more.

ESOT 2013 Report – Fantastic transplantations or transplantation fantasies? The new frontiers of abdominal organ transplantation

Written by | 18 Oct 2013

Andreas Tzakis , Weston, USA  – Advances in vascular reconstruction techniques in recent years has transformed the concept of multi-visceral or cluster transplantations from the very forefront of… read more.

ESOT 2013 Report – Who needs tolerance in the age of immunosuppression minimization?

Written by | 17 Oct 2013

Reducing or eliminating the need for chronic immunosuppressive therapy by inducing tolerance in the recipient immune system would have an astounding impact on clinical practice and scientists all… read more.

ESOT 2013 Report – Today’s patients, tomorrow’s outcomes: how can we manage risk factors to improve graft survival in renal transplantation?

Written by | 17 Oct 2013

by Maria Dalby – Kidney transplants could in principle last forever – the common assumption that kidney transplants inevitably deteriorate and fail is not supported by the latest… read more.

ESOT 2013 Report – DSA in 2013: What is it? How do we prevent it? How do we manage it?

Written by | 16 Oct 2013

by Maria Dalby – Donor-specific anti-human leukocyte antigen (HLA) antibodies, or DSAs, have emerged in recent years as one of the most important factors for predicting the outcome… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.